Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT07101796, who can take part
Where in China
- Respiratory Department of Peking University First HospitalBeijing, ChinaContact: Jing MaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Peking University First Hospital
- Trial code
- NCT07101796
- Record updated
- 3 August 2025
- Original description
This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.Read full original descriptionShow less
This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.
Inclusion: Age: 18~70 years old; Suspected OSA based on symptoms such as snoring, waking at night, daytime sleepiness, or requiring OSA screening due to related conditions; or confirmed OSA patients referred for sleep monitoring or CPAP pressure titration; Subjects are conscious, utterly independent in behavioral and cognitive ability, and able to answer questions independently; The patients gave informed consent to the study and cooperated with relevant treatment and evaluation.
Exclusion: Age below 18 or above 70 years old; No symptoms suggestive of OSA and no need for OSA screening; or patients without confirmed OSA; lacking full independence in behavior and cognitive ability, unable to answer questions independently; Patients who did not give informed consent or were unwilling to cooperate with treatment and evaluation.